Literature DB >> 31065833

Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes.

Yasushi Nishihira1, Tamar Gefen2,3, Qinwen Mao1,3, Christina Appin1, Missia Kohler1, Jamie Walker1, Rosa Rademakers4, Alfred Rademaker3,5, Emily Rogalski2,3, Sandra Weintraub2,3, Changiz Geula3, M-Marsel Mesulam3,6, Eileen H Bigio7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31065833      PMCID： PMC7186909          DOI： 10.1007/s00401-019-02024-w

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  4 in total

1.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

2.  Reappraisal of TDP-43 pathology in FTLD-U subtypes.

Authors:  Ian R Mackenzie; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2017-05-02       Impact factor: 17.088

3.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

4.  A harmonized classification system for FTLD-TDP pathology.

Authors:  Ian R A Mackenzie; Manuela Neumann; Atik Baborie; Deepak M Sampathu; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; John Q Trojanowski; David M A Mann; Virginia M Y Lee
Journal:  Acta Neuropathol       Date:  2011-06-05       Impact factor: 17.088
  4 in total
  4 in total

1.  Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.

Authors:  Manuela Neumann; Edward B Lee; Ian R Mackenzie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.

Authors:  Arenn F Carlos; Keith A Josephs
Journal:  J Neurol       Date:  2022-03-23       Impact factor: 6.682

3.  Signature laminar distributions of pathology in frontotemporal lobar degeneration.

Authors:  Daniel T Ohm; Katheryn A Q Cousins; Sharon X Xie; Claire Peterson; Corey T McMillan; Lauren Massimo; Katya Raskovsky; David A Wolk; Vivianna M Van Deerlin; Lauren Elman; Meredith Spindler; Andres Deik; John Q Trojanowski; Edward B Lee; Murray Grossman; David J Irwin
Journal:  Acta Neuropathol       Date:  2022-01-08       Impact factor: 17.088

4.  Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.

Authors:  Manuela Neumann; Petra Frick; Francesca Paron; Jonas Kosten; Emanuele Buratti; Ian R Mackenzie
Journal:  Acta Neuropathol       Date:  2020-08-10       Impact factor: 17.088
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.